Insmed Q1 2024 GAAP EPS $(1.06) Beats $(1.23) Estimate, Sales $75.500M Miss $77.758M Estimate
Author: Benzinga Newsdesk | May 09, 2024 07:09am
Insmed (NASDAQ:
INSM) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.23) by 13.82 percent. This is a 9.4 percent increase over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $75.500 million which missed the analyst consensus estimate of $77.758 million by 2.90 percent. This is a 15.77 percent increase over sales of $65.214 million the same period last year.
Posted In: INSM